Steroid-induced Hyperglycaemia in Hospitalised Patients: Does It Matter?
Overview
Authors
Affiliations
Steroid-induced hyperglycaemia is a common problem faced by endocrinologists in hospital wards. In this issue of Diabetologia, Popovic and colleagues (DOI 10.1007/s00125-016-4091-4 ) have conducted a subanalysis within a randomised controlled trial of prednisone therapy for community-acquired pneumonia. The authors found that the presence of diabetes or hyperglycaemia related to steroid therapy did not attenuate the clinical benefits of steroid therapy. The relevance and possible implications of these findings are discussed.
He X, Duan G, Lu J, Wang Y, Cai J, Tong Y Endocrine. 2024; 86(2):556-563.
PMID: 38822183 DOI: 10.1007/s12020-024-03841-0.
Pancreatic and Hepatic Injury in COVID-19: A Worse Prognosis in NAFLD Patients?.
Mengual-Moreno E, Nava M, Manzano A, Ariza D, DMarco L, Castro A Biomedicines. 2024; 12(2).
PMID: 38397885 PMC: 10887136. DOI: 10.3390/biomedicines12020283.
Masuda S, Yamada T, Hanzawa N Diabetol Int. 2023; 14(4):372-380.
PMID: 37781471 PMC: 10533434. DOI: 10.1007/s13340-023-00643-z.
Gerganova A, Assyov Y, Kamenov Z Front Clin Diabetes Healthc. 2023; 3:826006.
PMID: 36992767 PMC: 10012081. DOI: 10.3389/fcdhc.2022.826006.
Reges O, Test T, Hoshen M, Cicurel A, Saliba W, Greenland P BMJ Open Diabetes Res Care. 2023; 11(1).
PMID: 36669793 PMC: 9871869. DOI: 10.1136/bmjdrc-2022-003052.